Patent experts address misconceptions spread about the Bayh-Dole Act and § 1498 in a new letter to Congress.
"Dear Chairman Sanders, Ranking Member Cassidy, Chairman Smith, and Ranking Member Neal:
As former judges, former government officials, and scholars who are experts in patent law, healthcare policy, or both, we write to express our concerns about lobbying efforts for the government to impose price controls on patented drugs. Some activists and academics have written to Congress and to agency officials arguing that existing laws are “tools” for the government to impose price controls on patented drugs to lower drug prices.1 Their arguments mischaracterize these statutes by inaccurately claiming that Congress has endorsed the imposition of price controls on patented drugs. It has not..."